U.S. PHARMACOPEIA

Search USP29  
Cefuroxime for Injection
» Cefuroxime for Injection contains an amount of Cefuroxime Sodium equivalent to not less than 90.0 percent and not more than 120.0 percent of the labeled amount of cefuroxime (C16H16N4O8S).
Packaging and storage— Preserve in Containers for Sterile Solids as described under Injections 1.
Constituted solution— At the time of use, the constituted solution for intravenous administration prepared from Cefuroxime for Injection meets the requirements for Constituted Solutions under Labeling under Injections 1.
Bacterial endotoxins 85 It contains not more than 0.10 USP Endotoxin Unit per mg of cefuroxime.
Sterility 71 It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined.
Uniformity of dosage units 905: meets the requirements.
Procedure for content uniformity— Perform the Assay on individual containers using Assay preparation 1 or Assay preparation 2, or both, as appropriate.
Particulate matter 788: meets the requirements for small-volume injections.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Other requirements— It meets the requirements of the tests for Identification, pH, and Water under Cefuroxime Sodium. It meets also the requirements for Labeling under Injections 1.
Assay—
pH 3.4 Acetate buffer, Mobile phase, Internal standard solution, Standard preparation, and Chromatographic system— Proceed as directed in the Assay under Cefuroxime Sodium.
Assay preparation 1 (where it is represented as being in a single-dose container)—Constitute Cefuroxime for Injection in a volume of water, accurately measured, corresponding to the volume of solvent specified in the labeling. Withdraw all of the withdrawable contents, using a suitable hypodermic needle and syringe, and dilute quantitatively with water to obtain a solution containing about 1 mg of cefuroxime per mL. Immediately transfer 5.0 mL of the resulting solution to a 100-mL volumetric flask, add 20.0 mL of Internal standard solution, dilute with water to volume, and mix.
Assay preparation 2 (where the label states the quantity of cefuroxime in a given volume of constituted solution or suspension)—Constitute Cefuroxime for Injection in a volume of water, accurately measured, corresponding to the volume of solvent specified in the labeling. Dilute an accurately measured volume of the constituted solution or suspension quantitatively with water to obtain a solution containing about 1 mg of cefuroxime per mL. Immediately transfer 5.0 mL of the resulting solution to a 100-mL volumetric flask, add 20.0 mL of Internal standard solution, dilute with water to volume, and mix.
Procedure— Proceed as directed for Procedure in the Assay under Cefuroxime Sodium. Calculate the quantity, in mg, of cefuroxime (C16H16N4O8S) withdrawn from the container, or in the portion of constituted solution or suspension taken by the formula:
(L / D)(C)(RU / RS),
in which L is the labeled quantity, in mg of cefuroxime (C16H16N4O8S), in the container, or in the volume of constituted solution or suspension taken; D is the concentration, in mg of cefuroxime (C16H16N4O8S) per mL, of Assay preparation 1 or Assay preparation 2, based on the labeled quantity in the container or in the portion of constituted solution or suspension taken, respectively, and the extent of dilution; C is the concentration, in mg of cefuroxime (C16H16N4O8S) per mL, of the Standard preparation; and RU and RS are the peak response ratios of cefuroxime to the internal standard obtained from the Assay preparation and the Standard preparation, respectively. Where the test for Uniformity of dosage units has been performed using the Procedure for content uniformity, use the average of these determinations as the Assay value.
Auxiliary Information— Staff Liaison : Brian D. Gilbert, Ph.D., Scientist
Expert Committee : (MDANT05) Monograph Development-Antibiotics
USP29–NF24 Page 444
Phone Number : 1-301-816-8223